Yahoo Finance: Animal Regenerative Therapies Market Worldwide to Reach USD 870 Million by 2032, Driven by Advancements in Veterinary Biotechnology | Vyansa Intelligence
Animal Regenerative Therapies Market Worldwide to Reach USD 870 Million by 2032, Driven by Advancements in Veterinary Biotechnology | Vyansa Intelligence
Devdiscourse: EIB Invests €20M in BioLamina to Accelerate Cell Therapies and Animal-Free Drug Testing
EIB Invests €20M in BioLamina to Accelerate Cell Therapies and Animal-Free Drug Testing
Morningstar: Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics
Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics
Cell culture is a fundamental technique in biotechnology and life sciences that involves growing and maintaining living cells outside their natural environment, typically in a controlled laboratory ...
abc27: FDA Supports Innovation in Animal Biotechnology, Veterinary Products, Food for Animals Through New Comprehensive Agenda
FDA Supports Innovation in Animal Biotechnology, Veterinary Products, Food for Animals Through New Comprehensive Agenda
Reuters: R3 Bio Presented Its 2026 Research Report on Stem Cell-Based Integrated Systems to Replace Animal Testing
R3 Bio Presented Its 2026 Research Report on Stem Cell-Based Integrated Systems to Replace Animal Testing
WEST HAVEN, Conn. & SAN FRANCISCO--(BUSINESS WIRE)--Cellinfinity Bio, a privately held pioneer biotechnology company developing first/best-in-class cell therapy products against solid tumors and other ...
Philadelphia biotechnology startup Cell Surface Bio spun out of parent company Integral Molecular this week. Madison Tewey is a research associate at Cell Surface Bio describing data obtained using ...